Current Price Status
Stock is Trading within Range
Stock is trading within the fundamental outlook of the company and the industry average performance. Market is currently pricing of annual earning growth better than the industry average.
Company is in Positive Earning
- GENP current price is 10.68% below OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedGENP past 5-day return lagged behind the Agricultural Commodities/Milling industry average return by 4.06%
Above 30-Day AverageCurrent price RM7.3 is above than 30-day average RM7.16 by 2%
|Return (%)||GENP||Agricultural Commodities/Milling|
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Recent Positive Revenue Growth
GENP managed to achieve better revenue growth for past 2 quarters by average +17%.
Recent Positive Profit Growth
GENP managed to achieve better profit growth on the past 2 quarters by average +100%.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
GENP recent daily traded volume is -50% lower than past month average.
|Past 30-Day||Past 5-Day|
|6k daily||3k daily|
Price History Chart
Past 30-day Average Price: RM7.16
Market News & Investor Opinions
Stock Company Profile
GENTING PLANTATIONS BERHAD
Genting Plantations Bhd. engages in the provision of plantation and management services to its subsidiaries. It operates through the following segments: Plantation, Property, Biotechnology, Downstream Manufacturing, and Others. The Plantation segment comprises mainly of activities relating to oil palm plantations in Malaysia and Indonesia. The Property segment refers to the property development and property investments. The Biotechnology segment relates to the genomics research and development. The Downstream Manufacturing segment consists of downstream manufacturing activities. The Others segment includes insignificant business which are not reported separately. The company was founded on September 29, 1977 and is headquartered in Kuala Lumpur, Malaysia.